VANGUARD GROUP INC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$530,380,000
+57.5%
5,706,695
+0.9%
0.01%
+50.0%
Q3 2021$336,695,000
-12.2%
5,653,980
+0.6%
0.01%
-20.0%
Q2 2021$383,317,000
-1.2%
5,620,469
+0.5%
0.01%0.0%
Q1 2021$387,960,000
-4.1%
5,591,025
+6.2%
0.01%
-16.7%
Q4 2020$404,422,000
+5.6%
5,263,839
+2.7%
0.01%
-7.7%
Q3 2020$383,152,000
+18.2%
5,123,047
-0.5%
0.01%
+18.2%
Q2 2020$324,048,000
+63.6%
5,147,706
+9.2%
0.01%
+37.5%
Q1 2020$198,057,000
-4.3%
4,715,635
+3.5%
0.01%
+14.3%
Q4 2019$206,969,000
-1.2%
4,556,763
-0.4%
0.01%
-12.5%
Q3 2019$209,391,000
-21.5%
4,574,835
+0.5%
0.01%
-20.0%
Q2 2019$266,853,000
+30.6%
4,551,498
-0.1%
0.01%
+25.0%
Q1 2019$204,328,000
+11.8%
4,557,839
-2.8%
0.01%0.0%
Q4 2018$182,732,000
-15.0%
4,691,467
+0.5%
0.01%0.0%
Q3 2018$214,903,000
+8.6%
4,669,780
+2.9%
0.01%0.0%
Q2 2018$197,933,000
+17.8%
4,539,761
+6.7%
0.01%
+14.3%
Q1 2018$168,035,000
+54.4%
4,254,078
+32.7%
0.01%
+40.0%
Q4 2017$108,860,000
+35.2%
3,204,595
+1.5%
0.01%
+25.0%
Q3 2017$80,517,000
+93.0%
3,157,509
+27.7%
0.00%
+100.0%
Q2 2017$41,724,0002,473,2750.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Prosight Management, LP 163,133$7,467,0004.14%
PFM Health Sciences, LP 2,271,536$103,968,0003.07%
Partner Investment Management, L.P. 28,877$1,322,0002.26%
Atika Capital Management LLC 181,000$8,284,0001.74%
DAFNA Capital Management LLC 93,942$4,300,0001.62%
Asymmetry Capital Management, L.P. 16,272$745,0001.60%
First Light Asset Management, LLC 190,838$8,735,0001.32%
Perceptive Advisors 953,129$43,624,0001.18%
Rhenman & Partners Asset Management AB 155,000$7,094,0000.89%
Opus Point Partners Management, LLC 9,770$447,0000.81%
View complete list of ARENA PHARMACEUTICALS INC shareholders